SCHEMBL23535693

SCHEMBL23535693

COCCCCn1ncc2cc(C(=O)OC)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.56
MAOA P21397 1/20 0.56
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 3/20 0.43
HCAR3 P49019 1/20 0.42
KMO O15229 1/20 0.41
PDE1C Q14123 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
GAA P10253 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PLA2G4A P47712 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40
PTGER4 P35408 1/20 0.40
HDAC3 O15379 2/20 0.39
HDAC2 Q92769 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159473 1.00 MAOB (0.56) MAOBMAOAMAPK1KDM4EHCAR3
SCHEMBL23535815 0.90 MAOB (0.55) MAOBMAOAMAPK1HCAR3KMO
Lithium Ion SCHEMBL28962265 0.87 MAOB (0.53) MAOBMAOAMAPK1HCAR3KMO
SCHEMBL3411269 0.86 MAPK1 (0.47) MAOBMAOAMAPK1KDM4EKMO
SCHEMBL23467061 0.85 MAOA (0.52) MAOBMAOAKDM4EHCAR3KMO
SCHEMBL3492199 0.83 MAOA (0.50) MAOBMAOAKDM4EKMOPDE1C
SCHEMBL20594117 0.82 KDM4E (0.54) MAOBMAOAKDM4ECYP11B1CYP11B2
SCHEMBL20476630 0.82 KDM4C (0.49) MAOBMAOAMAPK1KDM4EHPGD
SCHEMBL29086227 0.81 MAOA (0.49) MAOBMAOAKDM4EKMOPDE1C
SCHEMBL24339233 0.81 MAOA (0.54) MAOBMAOAKDM4EHCAR3KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 MAOB 2008/4885MAOA 1214/4885MAPK1 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.